IRAK2 and neoplasm: In vivo, mice inoculated with the cell line overexpressing IRAK2 had significantly reduced tumor growth at baseline and in response to RT (50 Gy/10 fractions) compared to mice implanted with the parental radioresistant cell line (low IRAK2).